COMMUNIQUÉS West-GlobeNewswire

Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference Participation
22/06/2024
TERN-501 significantly improved the efficacy of a GLP-1 receptor agonist by normalizing energy expenditure, resulting in greater weight loss, increased fat mass loss and relative preservation of lean mass FOSTER CITY, [...]
Goodness Growth Holdings Announces Voting Results of Annual General and Special Meeting of Shareholders
21/06/2024
MINNEAPOLIS, June 21, 2024 (GLOBE NEWSWIRE) -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a cannabis company committed to providing safe access, quality products and [...]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
21/06/2024
SAN CARLOS, Calif., June 21, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal [...]
argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy
21/06/2024
VYVGART® Hytrulo is first and only neonatal Fc receptor (FcRn) blocker approved to treat chronic inflammatory demyelinating polyneuropathy (CIDP) First novel, precision mechanism of action in more than 30 years for [...]
Cronos Group Inc. Announces Results of 2024 Annual Meeting of Shareholders
21/06/2024
TORONTO, June 21, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders held yesterday, June 20, 2024 (the “Meeting”), [...]
Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 2024
21/06/2024
Daix, 21 June 2024 Pursuant to Article 241-2 of the AMF General Regulations ( Règlement Général de l’Autorité des marchés financiers ), the purpose of this description is to present the objectives and terms of the [...]
DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS AUTORISE PAR L'ASSEMBLEE GENERALE ORDINAIRE DU 20 JUIN 2024
21/06/2024
Daix, le 21 juin 2024 En application de l'article 241-2 du Règlement Général de l’Autorité des marchés financiers (AMF), le présent descriptif a pour finalité de présenter les objectifs ainsi que les modalités du [...]
Singular Genomics Announces 1-for-30 Reverse Stock Split
21/06/2024
SAN DIEGO, June 21, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and [...]
On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development
21/06/2024
TORONTO and HAIFA, Israel, June 21, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “ Company ” or “ NurExone ”), a pioneering biopharmaceutical company, welcomes Dr. [...]
Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
21/06/2024
WORCESTER, Mass., June 21, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell [...]
Inteleos’ Point-of-Care Ultrasound Certification Academy Launches Comprehensive Maternal Fetal Health Certification
21/06/2024
New OB 2nd/3rd Trimester Certificate Now Available, Completes Suite of Maternal Fetal Health Certification Products ROCKVILLE, Md., June 21, 2024 (GLOBE NEWSWIRE) -- Inteleos, a global non-profit healthcare [...]
Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024
21/06/2024
Daix (France), Long Island City (New York, United States), on June 21, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral [...]
Résultats des votes de l’Assemblée Générale Mixte des actionnaires réunies le 20 juin 2024
21/06/2024
Daix (France), Long Island City (New York, Etats-Unis), le 21 juin 2024 – Inventiva (Euronext Paris et Nasdaq : IVA) (la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites [...]
HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
21/06/2024
— Approval for previously treated metastatic colorectal cancer based on results from positive, global, Phase III FRESCO-2 Trial — — FRUZAQLA ® (fruquintinib) is the first novel targeted therapy in the EU for metastatic [...]
Standards Alliance Awards Inteleos Foundation to Expand Ultrasound Training in Kenya
21/06/2024
ROCKVILLE, Md., June 21, 2024 (GLOBE NEWSWIRE) -- The Inteleos Foundation, a public non-profit organization driving positive health outcomes through education in medical imaging, received a three-year, $180,000 subaward [...]
Inozyme Pharma Announces Presentation and Sponsored Symposium at the 11th International Conference on Children’s Bone Health (ICCBH)
21/06/2024
Results from a radiographic study describing skeletal features of pediatric patients with ENPP1 Deficiency will be presented BOSTON, June 21, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” [...]
ALK upgrades its full-year revenue and earnings outlook
21/06/2024
ALK ( ALKB:DC / OMX: ALK B / AKBLF ) today announced that the full-year financial outlook has been upgraded to reflect better than expected sales performance in Q2 and an improved outlook for the remainder of the year. [...]
ALK provides update on regulatory process for the house dust mite allergy tablet in China
21/06/2024
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that it has decided to withdraw the Biologic License Application (‘BLA’) for its house dust mite (‘HDM’) sublingual allergy immunotherapy tablet in China. ALK will [...]
BioSenic signs a new subscription agreement for a maximum of EUR 2.1M in convertible bonds
21/06/2024
PRESS RELEASE – PRIVILEGED INFORMATION Mont-Saint-Guibert, Belgium, June 21, 2024 6.00pm CEST – BioSenic (Euronext Brussels and Paris: BIOS) , the clinical stage company specializing in serious autoimmune and [...]

Pages